LLY

$1,255.40 1.90% $23.40
Aug 21, 2026 04:00 AM

Eli Lilly and Company is a global pharmaceutical company that develops and markets medications in various therapeutic areas, including diabetes, oncology, and immunology.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Aug 23, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Transform Your LLY Trading Now

Empower your trading with OHLCX Markets. Our comprehensive platform delivers precise analysis and strategic insights for LLY, designed to improve your trading outcomes. Boost your investment success with us and unlock new opportunities with our advanced system!

Take Action Now

Frequently Asked Questions

Yes, Eli Lilly has a history of paying dividends to its shareholders, with quarterly payments.

Yes, Eli Lilly is publicly traded on the New York Stock Exchange under the ticker symbol LLY.

Market capitalization changes frequently; check financial platforms for the latest information on LLY.

Key products include insulin therapies, cancer treatments, and medications for depression and autoimmune diseases.

For recent achievements, check their website for press releases and updates on new drug approvals and partnerships.

Eli Lilly invests heavily in R&D to innovate and bring new therapies to market, focusing on unmet medical needs.

You can access Eli Lilly’s financial statements on the investor relations section of their official website.

You can invest in LLY stock through a brokerage account or by consulting with a financial advisor.

Factors include clinical trial results, regulatory approvals, and overall market conditions in the pharmaceutical industry.

Eli Lilly engages in global health initiatives, providing access to medicines and supporting healthcare improvements worldwide.

Transform Your LLY Trading Now

Revolutionize your investment in LLY with OHLCX.com’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Start optimizing your trades today with OHLCX.com now and achieve better trading outcomes!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.